ORIGINAL ARTICLE

Blood pressure difference between regular hemodialysis and hemodialysis with hemoperfusion at Haji Adam Malik Hospital, Medan-Indonesia

Dedy Shauqi Fachrianda Situmorang , Alwi Thamrin Nasution, Syafrizal Nasution

Dedy Shauqi Fachrianda Situmorang
Division of Nephrology and Hypertension-Department of Internal Medicine Faculty of Medicine, Universitas Sumatera Utara Medan. Email: deddyshauqi@gmail.com

Alwi Thamrin Nasution
Division of Nephrology and Hypertension-Department of Internal Medicine Faculty of Medicine, Universitas Sumatera Utara Medan

Syafrizal Nasution
Division of Nephrology and Hypertension-Department of Internal Medicine Faculty of Medicine, Universitas Sumatera Utara Medan
Online First: April 29, 2021 | Cite this Article
Fachrianda Situmorang, D., Nasution, A., Nasution, S. 2021. Blood pressure difference between regular hemodialysis and hemodialysis with hemoperfusion at Haji Adam Malik Hospital, Medan-Indonesia. Bali Medical Journal 10(1): 234-237. DOI:10.15562/bmj.v10i1.846


Background: The differences of Hemodialysis and Hemoperfusion’s  combination can increase of Uremic Toxin clearance, average creatinine clearance, and Angiotensin elimination optimally. The hemodialysis and hemoperfusion’s  combination also can decrease blood pressure and reduce the use of Anti Hypertension drugs so that the number of cardiac events in CKD patients may decrease. The use of ABPM is chosen because this is the best method of automatic blood pressure which has the most accurate blood pressure measuring periodically.

Objective: This study aims to determine the difference of regular Hemodialysis and Hemodialysis with Hemoperfusion on blood pressure measured by using ABPM in Medan, North of Sumatra.

Methods: This study was a pre-experimental study which conducted since December 2013-March 2014 to the 20 regular hemodialysis patients. The measurement included anamnesis, height, weight, systolic and diastolic blood pressure among patients with regular hemodialysis and hemodialysis with hemoperfusion.
Results: The study found that about 3 of 20 subjects were out of the study. There was no significant difference found in systolic and diastolic blood pressure between regular hemodialysis and hemoperfusion group (P = 0.807 and 0.906, respectively) based on the T-paired test and Wilcoxon test.
Conclusion: There was no significant difference between blood pressure measured using ABPM on the combination of hemodialysis and hemoperfusion compared with regular hemodialysis

References

The United Renal Data System. Overall hospitalization and mortality. AM J Kidney Dis. 2010; 55(1) Suppl 1:A7.

Anees, M. Evaluation of nutritional status of patients on hemodialysis. Journal of the College of Physicians and Surgeons Pakistan. 2004; 14(11): 665-9.

Campbell, Katrina, L., Ash, S., Bauer, J., et al. Critical review of nutrition assessment tools to measure malnutrition in chronic kidney disease. Nutrition and Dietetics. 2007; 64(1): 23-30.

Herselman, M, Moosa MR, Kotze TJ, Kritzinger M, Wuister S, Mostert D. Protein-energy malnutrition as a risk factor for increased morbidity in long-term hemodialysis patients. Journal of Renal Nutrition 2000; 10(1):7-15.

Lowrie, E., Lew, N. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis. 1990; 15:458-482.

Steiber, A.L., Leon, J.B., Secker, D., McCarthy, M., et al. Multicenter study of the validity and reliability of subjective global assessment in the hemodialysis population. J Ren Nutr. 2007; 17:336–42.

Chen, S.J., Jiang, G.R., Shan, J.P., Lu, W., Huang, H.D., et al. Combination of maintenance hemodialysis with hemoperfusion: A safe and effective model of artificial kidney. International journal artificial organs. 2011; 34(4):339-347.

Winchester, J.F. Hemoperfusion. Dalam: Maher JF (editor). Replacement of Renal Function by Dialysis. Edisi ke-3. Holland: Kluwer Academic Publishers. 1989; 439-459.

Makhija, S., Baker, J. The Subjective Global Assessment: a review of its use in clinical practice. Nutr Clin Pract. 2008; 23(4); 405-9.

Vanholder RC, Glorieux GL. An overview of uremic toxicity. Hemodial Int. 2003;7(2):156-161. Medline. doi:10.1046/j.1492-7535.2003.00034.

Okonek S, Thomas HJ, Baldamus CA, Hofmann A. Hemoperfusion versus hemodialysis in the management of patients severely poisoned by organophosphorous insecticides and bipyridil herbicides. Artif Organs. 1979;4:341.

Okonek S. Probable progress in the therapy of organophosphate poisoning: Extracorporeal hemodialysis and hemoperfusion. Arch Toxicol. 1976;35:221

Nagler J, Braeckman RA, Willems JL, Verpooten GA, DeBroe ME. Combined hemoperfusion-hemodialysis in organophosphate poisoning. J Appl Toxicol. 1981;1:119

DeBroe ME, Verpooten GA, Christiansen MA, Rutsaert RJ, Halvoet J, Nagler J, Heydrickx A. Clinical experience with prolonged combined hemoperfusion-hemodialysis treatment of severe poisoning. Artif Organs. 1981;5:59

Rosenbaum JL, Kramer MS, Raja R, Boreyko C. Resin Hemoperfusion: A New Treatment for Acute Drug Intoxication. N Engl J Med 1971; 284:874-877

Juneja D, Singh O, Bhasin A, Gupta M, Saxena S, Chaturvedi A. Severe suicidal digoxin toxicity managed with resin hemoperfusion: A case report. Indian J Crit Care Med. 2012; 16(4): 231–2


No Supplementary Material available for this article.
Article Views      : 0
PDF Downloads : 0